Pharmacological Research · 2007 · 75 citations · 31 references
MedicinePharmacokineticsPharmacologyPharmacogeneticsPharmacogenomicsCytochrome P450 EnzymesCytochrome P450 InteractionsCytochrome P450-mediated MetabolismLipid-lowering TherapyCyp2d6 Drug MetabolismCyp2d6 GenotypeCyp2d6 GenotypingCyp2d6 PharmacogeneticsCytochrome P450 Genetic PolymorphismStatin Adverse EffectsStatin Pharmacogenomics
31
The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
Theresa H. Sullivan-Klose, Burhan I. Ghanayem, Douglas A. Bell et al. · Pharmacogenetics · 1996 · 587 citations
Medicine, Genetics, Pharmacology +17
Statin-Associated Myopathy with Normal Creatine Kinase Levels
Paul S Phillips, Richard Haas, Sergei I. Bannykh et al. · Annals of Internal Medicine · 2002 · 565 citations
Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction
Daniel I. Chasman · JAMA · 2004 · 457 citations